The Healthcare News Diaries
Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues medicine CEO Lars Fruergaard Jørgensen told lawmakers the business would take into consideration new talks with insurers concerning the listing prices of Wegovy and copyright should they pledge to maintain the medicines on their formularies.Hear the report 10 min This au